CommentaryA renaissance in marine pharmacology: From preclinical curiosity to clinical reality
Graphical abstract
Opinions provided by leaders in marine natural products will address potential reasons and perceptions from academic and pharmaceutical communities regarding the development of marine natural products as viable therapeutic entities.
Section snippets
Acknowledgements
The authors wish to acknowledge the contributors for their time and efforts to provide such a dynamic view of the development of marine natural products as therapeutics: Dr.’s Fenical, Ireland, Jacobs, Hamann, Alcaraz, Jaspars, Fusetani, Potts and Carter.
References (53)
- et al.
Marine pharmacology in 2001–2: antitumour and cytotoxic compounds
Eur J Cancer
(2004) - et al.
Marine pharmacology in 2003–2004: anti-tumour and cytotoxic compounds
Eur J Cancer
(2006) - et al.
Marine pharmacology in 2005–2006: antitumour and cytotoxic compounds
Eur J Cancer
(2008) - et al.
Marine pharmacology in 1999: compounds with antibacterial, anticoagulant, antifungal, anthelmintic, anti-inflammatory, antiplatelet, antiprotozoal and antiviral activities affecting the cardiovascular, endocrine, immune and nervous systems, and other miscellaneous mechanisms of action
Comp Biochem Physiol C: Toxicol Pharmacol
(2002) - et al.
Marine pharmacology in 2001–2002: marine compounds with anthelmintic, antibacterial, anticoagulant, antidiabetic, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems and other miscellaneous mechanisms of action
Comp Biochem Physiol C: Toxicol Pharmacol
(2005) - et al.
Marine pharmacology in 2003–4: marine compounds with anthelmintic antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action
Comp Biochem Physiol C: Toxicol Pharmacol
(2007) - et al.
Marine pharmacology in 2005-6: marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antituberculosis, and antiviral activities; affecting the cardiovascular, immune, and nervous systems and other miscellaneous mechanisms of action
Biochim Biophys Acta
(2009) - et al.
Marine actinobacteria: new opportunities for natural product search and discovery
Trends Microbiol
(2007) Bioactive natural products from marine cyanobacteria for drug discovery
Phytochemistry
(2007)Conus peptides: biodiversity-based discovery and exogenomics
J Biol Chem
(2006)
Ready for a comeback of natural products in oncology
Biochem Pharmacol
Contributions to the study of marine products. XL. The nucleosides of sponges. IV. Spongosine
J Org Chem
Contributions to the study of marine products. XXXII. The nucleosides of sponges. I.
J Org Chem
Contributions to the study of marine products. XLIII. The nucleosides of sponges. V. The synthesis of spongosine
J Org Chem
Ziconotide—a novel neuron-specific calcium channel blocker for the intrathecal treatment of severe chronic pain—a short review
Int J Clin Pharmacol Ther
Clinical impact of trabectedin (ecteinascidin-743) in advanced/metastatic soft tissue sarcoma
Expert Opin Pharmacother
Marine natural products
Nat Prod Rep
Marine natural products
Nat Prod Rep
Marine natural products
Nat Prod Rep
Marine natural products
Nat Prod Rep
Marine natural products
Nat Prod Rep
Marine natural products
Nat Prod Rep
Marine natural products
Nat Prod Rep
Marine natural products
Nat Prod Rep
Marine natural products
Nat Prod Rep
Marine pharmacology in 2000: antitumor and cytotoxic compounds
Int J Cancer
Cited by (114)
Synthesis and anti-tumor activity of marine alkaloids
2021, Bioorganic and Medicinal Chemistry LettersCitation Excerpt :The ocean is the birthplace of life and have rich in biological resources, it is a huge natural products screening resources 20. So far, researchers have found>300,000 species of marine organisms in the ocean, and more than a one million new species are expect to remain undiscovered 21–24. Marine organisms are secondary metabolites that have formed and accumulated a large number of special chemical structures and significant biological activities in the process of long-term evolution and metabolism in special environments such as high salt, high pressure, low temperature, hypoxia, and lack of light 25.
Secalonic acid D induces cell apoptosis in both sensitive and ABCG2-overexpressing multidrug resistant cancer cells through upregulating c-Jun expression
2019, Acta Pharmaceutica Sinica BCitation Excerpt :The marine organisms account for 78% of the total biomasses1,2.
The Mediterranean Zoanthid Parazoanthus axinellae as a Novel Source of Antimicrobial Compounds
2024, Journal of Marine Science and EngineeringMarine-derived microbes and molecules for drug discovery
2022, Inflammation and Regeneration